MED
MEDIFAST INC
$10.98
-$0.17(-1.52%)
50
Overall
60
Value
45
Tech
47
Quality
Market Cap
$132.77M
Volume
42.09K
52W Range
$9.22 - $15.46
Target Price
$12.00
Order:
Income Statement
| Metric | Trend | Chart | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $274.5M | $301.6M | $501.0M | $713.7M | $934.8M | $1.5B | $1.6B | $1.1B | $602.5M | $385.8M | ||
| Total Revenue | $274.5M | $301.6M | $501.0M | $713.7M | $934.8M | $1.5B | $1.6B | $1.1B | $602.5M | $385.8M | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $-68.9M | $-73.8M | $-121.1M | $176.8M | $237.0M | $398.5M | $458.2M | $296.2M | $157.8M | $110.6M | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $205.7M | $227.8M | $379.9M | $536.9M | $697.8M | $1.1B | $1.1B | $775.9M | $444.6M | $275.2M | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $178.8M | $188.2M | $310.8M | $622.6M | $800.7M | $911.4M | $955.6M | $649.4M | $441.7M | $289.4M | ||
| Research & Development | $-2.0M | $-1.5M | $-2.2M | $2.7M | $237.0M | $4.4M | $4.5M | $4.6M | $4.6M | -- | ||
| Research Expense | -- | -- | -- | $2.7M | $237.0M | $4.4M | -- | -- | -- | -- | ||
| Selling, General & Administrative | $178.8M | $188.2M | $310.8M | $445.8M | $563.7M | $911.4M | $955.6M | $649.4M | $441.7M | $289.4M | ||
| Selling & Marketing Expenses | $178.8M | $188.2M | $310.8M | $5.3M | $4.4M | $1.6M | $1.7M | $3.4M | $14.1M | -- | ||
| General & Administrative Expenses | $-1.3M | $-1.8M | -- | $445.8M | $563.7M | $911.4M | $955.6M | $649.4M | $441.7M | $289.4M | ||
| Promotion & Advertising | $-9.4M | $-7.7M | $-6.0M | $5.3M | $4.4M | $1.6M | -- | -- | -- | -- | ||
| Salaries & Wages | $-3.4M | $-4.3M | $-3.1M | $4.5M | $6.8M | -- | -- | $8.2M | $7.4M | $7.6M | ||
| Depreciation & Amortization | -- | -- | -- | $176.8M | -- | $5.7M | $7.9M | $10.0M | $17.4M | -- | ||
| Depreciation & Amortization | -- | -- | -- | $176.8M | -- | $5.7M | -- | -- | -- | -- | ||
| Amortization | -- | -- | -- | $176.8M | $200.0K | -- | -- | -- | -- | -- | ||
| Other Operating Expenses | $-700.0K | $-200.0K | $-100.0K | $3.1M | $3.6M | $5.6M | -- | -- | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $26.9M | $39.6M | $69.1M | $91.0M | $134.2M | $216.2M | $184.8M | $126.4M | $2.9M | $-14.2M | ||
| EBITDA | $33.0M | $45.2M | $75.6M | $100.1M | $138.5M | $223.0M | $195.7M | $139.4M | $11.7M | $3.1M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | -- | -- | -- | -- | -- | -- | $701.0K | $-2.5M | $-4.8M | $-5.5M | ||
| Intinc | $283.0K | $558.0K | $1.3M | $1.3M | $246.0K | $-231.0K | $-701.0K | -- | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $283.0K | $558.0K | $1.3M | $1.3M | $246.0K | $-231.0K | $-701.0K | $2.5M | $4.8M | $5.5M | ||
| Gain on Sale of Securities | $118.0K | $-82.0K | $-3.0K | -- | -- | -- | -- | -- | -- | -- | ||
| Other Income/Expense | $20.0K | $-136.0K | $-179.0K | $-29.0K | $140.0K | $-119.0K | $-46.0K | $95.0K | $3.9M | $-3.1M | ||
| Other Special Charges | $-20.0K | $136.0K | $179.0K | $29.0K | $-140.0K | $119.0K | $-46.0K | $-95.0K | $-3.9M | $3.1M | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | $-1.3M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Special Income Charges | $1.3M | -- | -- | -- | -- | -- | $-12.2M | -- | $-12.5M | -- | ||
| Other Impairment Of Capital Assets | $-6.1M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $27.1M | $40.3M | $70.5M | $92.4M | $134.2M | $216.1M | $184.8M | $126.3M | $-1.0M | $-11.2M | ||
| Pre-Tax Income | $27.1M | $40.3M | $70.5M | $92.4M | $134.3M | $216.1M | $184.1M | $128.8M | $3.8M | $-5.6M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $9.3M | $12.6M | $14.8M | $14.4M | $31.4M | $52.1M | $40.5M | $29.4M | $1.7M | $13.0M | ||
| NET INCOME | ||||||||||||
| Net Income | $17.8M | $27.7M | $55.8M | $77.9M | $102.9M | $164.0M | $143.6M | $99.4M | $2.1M | $-18.7M | ||
| Net Income (Continuing Operations) | $17.8M | $27.7M | $55.8M | $77.9M | $102.9M | $164.0M | $143.6M | $99.4M | $2.1M | $-18.7M | ||
| Net Income (Discontinued Operations) | $17.8M | $27.7M | $55.8M | $77.9M | $102.9M | $164.0M | $143.6M | $99.4M | $2.1M | $-18.7M | ||
| Net Income (Common Stockholders) | $17.8M | $27.7M | $55.8M | $77.9M | $102.9M | $164.0M | $143.6M | $99.4M | $2.1M | $-18.7M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | $-5.6M | ||
| TOTALS | ||||||||||||
| Total Expenses | $109.9M | $114.4M | $189.7M | $799.4M | $1.0B | $1.3B | $1.4B | $945.7M | $599.6M | $400.0M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $11.8M | $11.9M | $11.9M | $11.8M | $11.8M | $11.7M | $11.2M | $10.9M | $10.9M | $11.0M | ||
| Average Shares Outstanding (Diluted) | $11.9M | $12.1M | $12.1M | $12.1M | $11.8M | $11.8M | $11.3M | $10.9M | $11.0M | $11.0M | ||
| Shares Outstanding | $11.9M | $12.0M | $11.9M | $11.8M | $11.8M | $11.5M | $10.8M | $10.9M | $10.9M | $11.0M | ||
| Basic EPS | $1.51 | $2.32 | $4.67 | $6.62 | $8.74 | $14.01 | $12.82 | $9.13 | $0.19 | $-1.7 | ||
| Basic EPS (Continuing Operations) | $1.51 | $2.32 | -- | $6.62 | $8.74 | $14.01 | $12.82 | $9.13 | $0.19 | $-1.7 | ||
| Diluted EPS | $1.49 | $2.29 | $4.62 | $6.43 | $8.68 | $13.89 | $12.73 | $9.1 | $0.19 | $-1.7 | ||
| Diluted EPS (Continuing Operations) | $1.49 | $2.29 | -- | $6.43 | $8.68 | $13.89 | $12.73 | $9.1 | $0.19 | $-1.7 | ||
| Dividend Per Share | $1.07 | $1.44 | $2.19 | $3.38 | $4.52 | $5.68 | $6.56 | $4.95 | -- | -- | ||
| OTHER METRICS | ||||||||||||
| Loss And Loss Adjustment Expected Incurred | -- | -- | -- | $176.8M | -- | -- | -- | -- | -- | -- | ||
| Other Gand A | $-1.3M | $-1.8M | -- | $445.8M | $563.7M | $911.4M | $955.6M | $649.4M | $441.7M | $289.4M | ||
| Rent And Landing Fees | $-1.3M | $-1.8M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $178.8M | $188.2M | $310.8M | -- | -- | -- | -- | -- | -- | -- | ||
| Restruct | $-1.3M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MED | $10.98 | -1.5% | 42.09K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |